跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
KISQALI 200 MG COMPRIMIDOS RECUBIERTOS CON PELICULA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
KISQALI 200 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Approved
STANDARD
KISQALI 200 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Novartis Europharm Limited
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jan 26, 2024
Approval ID
5011b65d6c5fb0f3
Company
Novartis Europharm Limited
Type
Standard
Approval Details
Approval Id
5011b65d6c5fb0f3
Drug Cima Aemps Name
KISQALI 200 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Register Number
1171221001IP1
Holder Company Name
Novartis Europharm Limited
Marketing Company Name
Abacus Medicine A/S
Holder Company Detail Path
/organization/novartis-europharm-limited
Authorization Date
2024-01-26
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
200 mg
Route Of Administration
VÍA ORAL
Prescription Type
Diagnóstico Hospitalario
Commercialized
Yes
Company Name
Novartis Europharm Limited
Company Detail Path
/organization/novartis-europharm-limited
Company Information
Pharmaceutical Company Name
NOVARTIS EUROPHARM LIMITED
Country Name
United Kingdom
City Name
camberley,country_gb
Address
200 Frimley Business Park
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jan 26, 2024
Approval ID
5011b65d6c5fb0f3
Type
Standard
Back to CIMA-AEMPS Approvals
